Its a field thats already undergoing a revolution, with millions of people across the US now using semaglutide and tirzepatide, sold as Wegovy and Zepbound for weight loss (and for diabetes as the better-known Ozempic and Mounjaro)
These results indicate that DFP can interact with brain iron and potentially ameliorate neurodegenerative and behavioral alterations
Such interventions are key for supporting overall health, and even without GLP1 RA use resulted in sustained 10% weight loss for nearly 30% of patients with T2D at eight years
After 64 weeks, people on the Wegovy pill lost an average of 13.6 percent of their starting body weight, compared with 2.2 percent for the placebo
Chalasani N, Gorski JC, Asghar MS, Asghar A, Foresman B, Hall SD, Crabb DW (2003) Hepatic cytochrome P450 2E1 activity in nondiabetic patients with nonalcoholic steatohepatitis
Supply Chain Issues and Shortages Across Europe, there have been shortages of GLP-1 medicines, which affect both diabetes and weight loss patients